pre-update Archives

Blog

3 Major Implications of New European Clinical Trial Regulations

Have you heard the buzz around the new European Union Clinical Trial Regulations (EU-CTR) for…

CertaraAugust 25, 2022

Blog

Mind-blowing applications of QSP in drug development: Part 2

Part 2 of this blog series dives further into the June 2022 podcast with R&D…

CertaraAugust 15, 2022

Blog

Why are Human Radiolabeled Mass-balance Studies Important in Clinical Pharmacology & Drug Development?

Human mass-balance studies are also called “C-14 studies” or “Absorption, Metabolism, and Excretion (AME) studies.”…

CertaraAugust 5, 2022

Blog

Mind-blowing applications of QSP in drug development: Part 1

R&D World editors, Paul Heney and Aimee Kalnoskas, have their minds blown — multiple times!…

CertaraAugust 4, 2022

Video

Certara DIA Software Promo

CertaraJuly 18, 2022

Brochure

Simcyp® Discovery Simulator

Tailored for discovery and translational scientists, Simcyp® Discovery Simulator is an intuitive software that delivers…

CertaraJuly 14, 2022

Press Release

Certara to Report Second Quarter 2022 Financial Results on August 9th, 2022

PRINCETON, N.J.— July 12, 2022-- Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today…

CertaraJuly 12, 2022

Blog

Highlights from the FDA-ASCO Workshop on Dose Optimization for Oncology Drugs

The FDA-ASCO (American Society of Clinical Oncology) workshop on oncology dose optimization (3-5 May 2022)…

CertaraJuly 8, 2022

On-Demand Webinar

Using Clinical Pharmacology & Pharmacometrics to Accelerate Cell Therapy Development: A Patient’s CAR-T Journey

Cell therapies aim to treat, prevent, or potentially cure diseases. They are a relatively new…

CertaraJuly 8, 2022

Blog

Why FDA’s New Guidance on Circulating Tumor DNA is Critical for Oncology Early Clinical Drug Development

2022 is shaping up to be the “year of the guidance” as the FDA has…

CertaraJuly 1, 2022

pre-update

3 Major Implications of New European Clinical Trial Regulations

Mind-blowing applications of QSP in drug development: Part 2

Why are Human Radiolabeled Mass-balance Studies Important in Clinical Pharmacology & Drug Development?

Mind-blowing applications of QSP in drug development: Part 1

Certara DIA Software Promo

Simcyp® Discovery Simulator

Certara to Report Second Quarter 2022 Financial Results on August 9th, 2022

Highlights from the FDA-ASCO Workshop on Dose Optimization for Oncology Drugs

Using Clinical Pharmacology & Pharmacometrics to Accelerate Cell Therapy Development: A Patient’s CAR-T Journey

Why FDA’s New Guidance on Circulating Tumor DNA is Critical for Oncology Early Clinical Drug Development

Newsletter sign up

Quick links

Solutions

Contact